-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Phathom Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q2 2024.
- Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $6.1M, a 15.9% decline year-over-year.
- Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $42.4M, a 58.5% increase year-over-year.
- Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45M, a 86.6% increase from 2022.
- Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24.1M, a 43.5% increase from 2021.
- Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.8M, a 188% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)